{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T19:54:43Z","timestamp":1776023683190,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,8,13]],"date-time":"2018-08-13T00:00:00Z","timestamp":1534118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>MicroRNAs (miRNAs) are dysregulated in many tumors; however, miRNA regulation in parathyroid tumors remains poorly understood. To identify differentially expressed miRNAs between sporadic and hereditary parathyroid tumors and to analyze their correlation with clinicopathological features, a microarray containing 887 miRNAs was performed; then, the differentially expressed miRNAs were validated by qRT-PCR using 25 sporadic and 12 hereditary parathyroid tumors and 24 normal parathyroid tissue samples. A receiver operating characteristic curve (ROC) analysis was applied to evaluate the utility of the miRNAs for distinguishing parathyroid tumor types. Compared to the miRNAs in the normal parathyroid tissues, 10 miRNAs were differentially expressed between the sporadic and hereditary parathyroid tumors. Seven of these miRNAs (let-7i, miR-365, miR-125a-3p, miR-125a-5p, miR-142-3p, miR-193b, and miR-199b-5p) were validated in the parathyroid tumor samples. Among these miRNAs, only miR-199b-5p was differentially expressed (<jats:italic>P<\/jats:italic>\u2009&lt;\u20090.001); miR-199b-5p was significantly downregulated and negatively associated with PTH levels (\u03b3\u2009=\u2009\u22120.579, <jats:italic>P<\/jats:italic>\u2009=\u20090.002) in the sporadic tumors but was upregulated in the hereditary tumors. This miRNA showed 67% sensitivity and 100% specificity for distinguishing sporadic and hereditary parathyroid tumors. These results reveal altered expression of a miRNA between sporadic and hereditary parathyroid tumors and the potential role of miR-199b-5p as a novel biomarker for distinguishing these two types of parathyroid tumors.<\/jats:p>","DOI":"10.1038\/s41598-018-30484-9","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T09:30:41Z","timestamp":1533634241000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Differential expression of miRNA199b-5p as a novel biomarker for sporadic and hereditary parathyroid tumors"],"prefix":"10.1038","volume":"8","author":[{"given":"Sena","family":"Hwang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4155-6035","authenticated-orcid":false,"given":"Jong Ju","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7516-7372","authenticated-orcid":false,"given":"Se Hoon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon Jung","family":"Chung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sun Yong","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang Jong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4227-5638","authenticated-orcid":false,"given":"Yumie","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,13]]},"reference":[{"key":"30484_CR1","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1002\/jbmr.5650061409","volume":"6","author":"LJ Melton III","year":"1991","unstructured":"Melton, L. J. III Epidemiology of primary hyperparathyroidism. Journal of Bone and Mineral Research 6, S25\u2013S30 (1991).","journal-title":"Journal of Bone and Mineral Research"},{"key":"30484_CR2","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1043\/1543-2165(2008)132[1251:PHACP]2.0.CO;2","volume":"132","author":"RA DeLellis","year":"2008","unstructured":"DeLellis, R. A., Mazzaglia, P. & Mangray, S. Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med 132, 1251\u20131262, https:\/\/doi.org\/10.1043\/1543-2165(2008)132[1251:PHACP]2.0.CO;2 (2008).","journal-title":"Arch Pathol Lab Med"},{"key":"30484_CR3","doi-asserted-by":"publisher","first-page":"5658","DOI":"10.1210\/jcem.86.12.8070","volume":"86","author":"ML Brandi","year":"2001","unstructured":"Brandi, M. L. et al. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab 86, 5658\u20135671, https:\/\/doi.org\/10.1210\/jcem.86.12.8070 (2001).","journal-title":"J Clin Endocrinol Metab"},{"key":"30484_CR4","doi-asserted-by":"publisher","first-page":"928383","DOI":"10.1155\/2010\/928383","volume":"2010","author":"G Piecha","year":"2010","unstructured":"Piecha, G., Chudek, J. & Wiecek, A. Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1. Int J Endocrinol 2010, 928383, https:\/\/doi.org\/10.1155\/2010\/928383 (2010).","journal-title":"Int J Endocrinol"},{"key":"30484_CR5","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1002\/jbmr.125","volume":"25","author":"DM Lourenco Jr","year":"2010","unstructured":"Lourenco, D. M. Jr et al. Early-onset, progressive, frequent, extensive, and severe bone mineral and renal complications in multiple endocrine neoplasia type 1-associated primary hyperparathyroidism. J Bone Miner Res 25, 2382\u20132391, https:\/\/doi.org\/10.1002\/jbmr.125 (2010).","journal-title":"J Bone Miner Res"},{"key":"30484_CR6","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1359\/jbmr.090304","volume":"24","author":"C Eller-Vainicher","year":"2009","unstructured":"Eller-Vainicher, C. et al. Sporadic and MEN1-related primary hyperparathyroidism: differences in clinical expression and severity. J Bone Miner Res 24, 1404\u20131410, https:\/\/doi.org\/10.1359\/jbmr.090304 (2009).","journal-title":"J Bone Miner Res"},{"key":"30484_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/SLA.0b013e31815efda5","volume":"247","author":"JA Norton","year":"2008","unstructured":"Norton, J. A. et al. Prospective study of surgery for primary Hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 (MEN1), and Zollinger-Ellison syndrome (ZES): long-term outcome of a more virulent form of HPT. Annals of surgery 247, 501 (2008).","journal-title":"Annals of surgery"},{"key":"30484_CR8","doi-asserted-by":"publisher","first-page":"141","DOI":"10.6061\/clinics\/2012(Sup01)23","volume":"67","author":"F Giusti","year":"2012","unstructured":"Giusti, F., Tonelli, F. & Brandi, M. L. Primary hyperparathyroidism in multiple endocrine neoplasia type 1: when to perform surgery? Clinics 67, 141\u2013144 (2012).","journal-title":"Clinics"},{"key":"30484_CR9","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1055\/s-2001-16944","volume":"33","author":"M Katai","year":"2001","unstructured":"Katai, M., Sakurai, A., Ikeo, Y. & Hashizume, K. Primary hyperparathyroidism in patients with multiple endocrine neoplasia type 1: comparison with sporadic parathyroid adenomas. Horm Metab Res 33, 499\u2013503, https:\/\/doi.org\/10.1055\/s-2001-16944 (2001).","journal-title":"Horm Metab Res"},{"key":"30484_CR10","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1072-7515(98)00317-2","volume":"188","author":"AC Berger","year":"1999","unstructured":"Berger, A. C. et al. Heterogeneous gland size in sporadic multiple gland parathyroid hyperplasia. Journal of the American College of Surgeons 188, 382\u2013389 (1999).","journal-title":"Journal of the American College of Surgeons"},{"key":"30484_CR11","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1038\/nature10275","volume":"476","author":"AH Berger","year":"2011","unstructured":"Berger, A. H., Knudson, A. G. & Pandolfi, P. P. A continuum model for tumour suppression. Nature 476, 163\u2013169, https:\/\/doi.org\/10.1038\/nature10275 (2011).","journal-title":"Nature"},{"key":"30484_CR12","doi-asserted-by":"publisher","first-page":"5848","DOI":"10.1200\/JCO.2009.24.0317","volume":"27","author":"MV Iorio","year":"2009","unstructured":"Iorio, M. V. & Croce, C. M. MicroRNAs in cancer: small molecules with a huge impact. J Clin Oncol 27, 5848\u20135856, https:\/\/doi.org\/10.1200\/JCO.2009.24.0317 (2009).","journal-title":"J Clin Oncol"},{"key":"30484_CR13","doi-asserted-by":"publisher","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","volume":"65","author":"MV Iorio","year":"2005","unstructured":"Iorio, M. V. et al. MicroRNA gene expression deregulation in human breast cancer. Cancer research 65, 7065\u20137070 (2005).","journal-title":"Cancer research"},{"key":"30484_CR14","doi-asserted-by":"publisher","first-page":"135","DOI":"10.4149\/neo_2013_018","volume":"60","author":"J Qi","year":"2013","unstructured":"Qi, J., Wang, J., Katayama, H., Sen, S. & Liu, S.-m. Circulating microRNAs (cmiRNAs) as novel potential biomarkers for hepatocellular carcinoma. Neoplasma 60, 135 (2013).","journal-title":"Neoplasma"},{"key":"30484_CR15","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1007\/s12038-011-9083-4","volume":"36","author":"J Wang","year":"2011","unstructured":"Wang, J. & Sen, S. MicroRNA functional network in pancreatic cancer: from biology to biomarkers of disease. Journal of biosciences 36, 481\u2013491 (2011).","journal-title":"Journal of biosciences"},{"key":"30484_CR16","doi-asserted-by":"publisher","first-page":"11586","DOI":"10.3390\/molecules190811586","volume":"19","author":"Y Peng","year":"2014","unstructured":"Peng, Y. et al. Expression profile and clinical significance of microRNAs in papillary thyroid carcinoma. Molecules 19, 11586\u201311599 (2014).","journal-title":"Molecules"},{"key":"30484_CR17","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1677\/ERC-09-0134","volume":"17","author":"S Corbetta","year":"2010","unstructured":"Corbetta, S. et al. Differential expression of microRNAs in human parathyroid carcinomas compared with normal parathyroid tissue. Endocr Relat Cancer 17, 135\u2013146, https:\/\/doi.org\/10.1677\/ERC-09-0134 (2010).","journal-title":"Endocr Relat Cancer"},{"key":"30484_CR18","doi-asserted-by":"publisher","first-page":"1158","DOI":"10.1245\/s10434-010-1359-7","volume":"18","author":"R Rahbari","year":"2011","unstructured":"Rahbari, R. et al. Identification of differentially expressed microRNA in parathyroid tumors. Ann Surg Oncol 18, 1158\u20131165, https:\/\/doi.org\/10.1245\/s10434-010-1359-7 (2011).","journal-title":"Ann Surg Oncol"},{"key":"30484_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1530\/JME-11-0189","volume":"49","author":"V Vaira","year":"2012","unstructured":"Vaira, V. et al. The microRNA cluster C19MC is deregulated in parathyroid tumours. Journal of molecular endocrinology 49, 115\u2013124 (2012).","journal-title":"Journal of molecular endocrinology"},{"key":"30484_CR20","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1007\/s12020-018-1551-2","volume":"60","author":"Y Hu","year":"2018","unstructured":"Hu, Y. et al. Verification of candidate microRNA markers for parathyroid carcinoma. Endocrine 60, 246\u2013254 (2018).","journal-title":"Endocrine"},{"key":"30484_CR21","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/0002-9610(86)90436-8","volume":"152","author":"WA Zamboni","year":"1986","unstructured":"Zamboni, W. A. & Folse, R. Adenoma weight: a predictor of transient hypocalcemia after parathyroidectomy. Am J Surg 152, 611\u2013615 (1986).","journal-title":"Am J Surg"},{"key":"30484_CR22","first-page":"1107","volume":"98","author":"R Rutledge","year":"1985","unstructured":"Rutledge, R., Stiegel, M., Thomas, C. G. & Wild, R. E. Jr. The relation of serum calcium and immunoparathormone levels to parathyroid size and weight in primary hyperparathyroidism. Surgery 98, 1107\u20131112 (1985).","journal-title":"Surgery"},{"key":"30484_CR23","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1172-8-50","volume":"8","author":"BA Twigt","year":"2013","unstructured":"Twigt, B. A., Scholten, A., Valk, G. D., Rinkes, I. H. B. & Vriens, M. R. Differences between sporadic and MEN related primary hyperparathyroidism; clinical expression, preoperative workup, operative strategy and follow-up. Orphanet J Rare Dis 8, 50 (2013).","journal-title":"Orphanet J Rare Dis"},{"key":"30484_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1530\/EJE-12-0210","volume":"167","author":"JM de Laat","year":"2012","unstructured":"de Laat, J. M. et al. Predicting the risk of multiple endocrine neoplasia type 1 for patients with commonly occurring endocrine tumors. European Journal of Endocrinology 167, 181\u2013187 (2012).","journal-title":"European Journal of Endocrinology"},{"key":"30484_CR25","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1056\/NEJM198907273210402","volume":"321","author":"E Friedman","year":"1989","unstructured":"Friedman, E. et al. Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1. N Engl J Med 321, 213\u2013218, https:\/\/doi.org\/10.1056\/NEJM198907273210402 (1989).","journal-title":"N Engl J Med"},{"key":"30484_CR26","doi-asserted-by":"publisher","first-page":"7405","DOI":"10.1158\/0008-5472.CAN-04-2063","volume":"64","author":"CJ Haven","year":"2004","unstructured":"Haven, C. J. et al. Gene expression of parathyroid tumors: molecular subclassification and identification of the potential malignant phenotype. Cancer Res 64, 7405\u20137411, https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-2063 (2004).","journal-title":"Cancer Res"},{"key":"30484_CR27","doi-asserted-by":"publisher","first-page":"2224","DOI":"10.1007\/s00268-009-0022-6","volume":"33","author":"G Westin","year":"2009","unstructured":"Westin, G., Bjorklund, P. & Akerstrom, G. Molecular genetics of parathyroid disease. World J Surg 33, 2224\u20132233, https:\/\/doi.org\/10.1007\/s00268-009-0022-6 (2009).","journal-title":"World J Surg"},{"key":"30484_CR28","doi-asserted-by":"publisher","first-page":"275802","DOI":"10.4061\/2011\/275802","volume":"2011","author":"MI Alvelos","year":"2011","unstructured":"Alvelos, M. I., Mendes, M. & Soares, P. Molecular alterations in sporadic primary hyperparathyroidism. Genet Res Int 2011, 275802, https:\/\/doi.org\/10.4061\/2011\/275802 (2011).","journal-title":"Genet Res Int"},{"key":"30484_CR29","first-page":"5553","volume":"60","author":"S Uchino","year":"2000","unstructured":"Uchino, S. et al. Screening of the Men1 gene and discovery of germ-line and somatic mutations in apparently sporadic parathyroid tumors. Cancer Res 60, 5553\u20135557 (2000).","journal-title":"Cancer Res"},{"key":"30484_CR30","doi-asserted-by":"publisher","first-page":"e39767","DOI":"10.1371\/journal.pone.0039767","volume":"7","author":"E Luzi","year":"2012","unstructured":"Luzi, E. et al. The negative feedback-loop between the oncomir Mir-24-1 and menin modulates the Men1 tumorigenesis by mimicking the \u201cKnudson\u2019s second hit\u201d. PLoS One 7, e39767, https:\/\/doi.org\/10.1371\/journal.pone.0039767 (2012).","journal-title":"PLoS One"},{"key":"30484_CR31","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1007\/s00428-017-2158-3","volume":"471","author":"VK Grolmusz","year":"2017","unstructured":"Grolmusz, V. K. et al. MEN1 mutations and potentially MEN1-targeting miRNAs are responsible for menin deficiency in sporadic and MEN1 syndrome-associated primary hyperparathyroidism. Virchows Archiv 471, 401\u2013411 (2017).","journal-title":"Virchows Archiv"},{"key":"30484_CR32","first-page":"1743","volume":"9","author":"E Luzi","year":"2017","unstructured":"Luzi, E. et al. Analysis of differentially expressed microRNAs in MEN1 parathyroid adenomas. American journal of translational research 9, 1743 (2017).","journal-title":"American journal of translational research"},{"key":"30484_CR33","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1093\/neuonc\/nos002","volume":"14","author":"I Andolfo","year":"2012","unstructured":"Andolfo, I. et al. The micro-RNA 199b-5p regulatory circuit involves Hes1, CD15, and epigenetic modifications in medulloblastoma. Neuro Oncol 14, 596\u2013612, https:\/\/doi.org\/10.1093\/neuonc\/nos002 (2012).","journal-title":"Neuro Oncol"},{"key":"30484_CR34","doi-asserted-by":"publisher","first-page":"1648","DOI":"10.1016\/j.humpath.2013.01.016","volume":"44","author":"KY Won","year":"2013","unstructured":"Won, K. Y. et al. MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma. Hum Pathol 44, 1648\u20131655, https:\/\/doi.org\/10.1016\/j.humpath.2013.01.016 (2013).","journal-title":"Hum Pathol"},{"key":"30484_CR35","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/ajh.23129","volume":"87","author":"AJ Favreau","year":"2012","unstructured":"Favreau, A. J., Cross, E. L. & Sathyanarayana, P. miR-199b-5p directly targets PODXL and DDR1 and decreased levels of miR-199b-5p correlate with elevated expressions of PODXL and DDR1 in acute myeloid leukemia. Am J Hematol 87, 442\u2013446, https:\/\/doi.org\/10.1002\/ajh.23129 (2012).","journal-title":"Am J Hematol"},{"key":"30484_CR36","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1111\/j.1440-1746.2011.06758.x","volume":"26","author":"C Wang","year":"2011","unstructured":"Wang, C. et al. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1alpha in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients. J Gastroenterol Hepatol 26, 1630\u20131637, https:\/\/doi.org\/10.1111\/j.1440-1746.2011.06758.x (2011).","journal-title":"J Gastroenterol Hepatol"},{"key":"30484_CR37","doi-asserted-by":"publisher","unstructured":"Jiang, G. et al. Expression levels of microRNA-199 and hypoxia-inducible factor-1 alpha in brain tissue of patients with intractable epilepsy. Int J Neurosci 1\u201329, https:\/\/doi.org\/10.3109\/00207454.2014.994209 (2014).","DOI":"10.3109\/00207454.2014.994209"},{"key":"30484_CR38","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1089\/152308603768295212","volume":"5","author":"N Goda","year":"2003","unstructured":"Goda, N., Dozier, S. J. & Johnson, R. S. HIF-1 in cell cycle regulation, apoptosis, and tumor progression. Antioxid Redox Signal 5, 467\u2013473, https:\/\/doi.org\/10.1089\/152308603768295212 (2003).","journal-title":"Antioxid Redox Signal"},{"key":"30484_CR39","doi-asserted-by":"publisher","first-page":"429","DOI":"10.5483\/BMBRep.2013.46.9.180","volume":"46","author":"YI Cha","year":"2013","unstructured":"Cha, Y. I. & Kim, H. S. Emerging role of sirtuins on tumorigenesis: possible link between aging and cancer. BMB Rep 46, 429\u2013438 (2013).","journal-title":"BMB Rep"},{"key":"30484_CR40","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1677\/erc.1.01294","volume":"13","author":"S Fontaniere","year":"2006","unstructured":"Fontaniere, S. et al. Gene expression profiling in insulinomas of Men1 \u03b2-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic \u03b2-cell tumorigenesis. Endocrine-Related Cancer 13, 1223\u20131236 (2006).","journal-title":"Endocrine-Related Cancer"},{"key":"30484_CR41","doi-asserted-by":"crossref","unstructured":"Dweep, H., Gretz, N. & Sticht, C. miRWalk database for miRNA\u2013target interactions in RNA Mapping 289\u2013305 (Springer, 2014).","DOI":"10.1007\/978-1-4939-1062-5_25"},{"key":"30484_CR42","doi-asserted-by":"publisher","first-page":"D296","DOI":"10.1093\/nar\/gkx1067","volume":"46","author":"C-H Chou","year":"2017","unstructured":"Chou, C.-H. et al. miRTarBase update 2018: a resource for experimentally validated microRNA-target interactions. Nucleic acids research 46, D296\u2013D302 (2017).","journal-title":"Nucleic acids research"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30484-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30484-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30484-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T08:34:09Z","timestamp":1671611649000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-30484-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,13]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["30484"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-30484-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,13]]},"assertion":[{"value":"15 March 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"12016"}}